This is a return to form for Dupixent, which was one of the top Rx and OTC pharma brands in 2023 but was outperformed by the likes of Vicks and Rinvoq in early 2024.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,